---
schema_version: "secwatch.filing_event.v1"
accession: "0001022079-25-000008"
form_type: "8-K"
ticker: "DGX"
cik: "0001022079"
company_name: "QUEST DIAGNOSTICS INC"
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:04:25.810273+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Quest Diagnostics Q4 revenue $2.62B (+14.5%), adjusted EPS $2.23 (+3.7%); raises dividend 6.7% to $0.80

## Summary
- Q4 revenue $2.62B (+14.5% YoY); reported diluted EPS $1.95 (+14.7%); adjusted diluted EPS $2.23 (+3.7%).
- Full year 2024 revenue $9.87B (+6.7%); reported EPS $7.69 (+2.7%); adjusted EPS $8.93 (+2.5%).
- FY2025 guidance: revenue $10.70-10.85B; reported EPS $8.34-8.59; adjusted EPS $9.55-9.80; cash ops ~$1.45B.
- Quarterly dividend raised 6.7% to $0.80 ($3.20 annual), payable Apr 21, 2025 to holders of record Apr 7, 2025.
- Completed 8 acquisitions in 2024 (including LifeLabs); extended health plan access to >90% of in-network lives.

## SEC filing metadata
- accession: 0001022079-25-000008
- form_type: 8-K
- ticker: DGX
- cik: 0001022079
- company_name: QUEST DIAGNOSTICS INC
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022079/000102207925000008/0001022079-25-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022079/000102207925000008/dgx-20250130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001022079-25-000008
- JSON: https://secwatch.observer/filing/0001022079-25-000008.json
- Plain text: https://secwatch.observer/filing/0001022079-25-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.